Diagnostic yield of neuroimaging in syncope patients without high‐risk symptoms indicating neurological syncope
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Emergency Medicine"
DOI: 10.1016/j.ajem.2018.05.033
Abstract: Objectives: Diagnostic tests are widely used for patients with syncope in the emergency department (ED). This study aimed to determine the diagnostic yield of neuroimaging in patients with syncope without high‐risk symptoms. Methods: Adult patients… read more here.
Keywords: syncope; high risk; without high; yield neuroimaging ... See more keywords
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features.
Sign Up to like & getrecommendations! Published in 2021 at "Current problems in cancer"
DOI: 10.1016/j.currproblcancer.2021.100788
Abstract: Lenalidomide and low-dose dexamethasone (Rd) are a standard treatment for older adults with multiple myeloma (MM). Lenalidomide monotherapy has rarely been evaluated for newly diagnosed transplant-ineligible MM patients. This multicenter phase II trial evaluated a… read more here.
Keywords: response adapted; ineligible patients; transplant ineligible; newly diagnosed ... See more keywords
Timing and Clinical Features of Spontaneous Decrease in Size of Small Pancreatic Cystic Lesions without High-Risk Stigmata
Sign Up to like & getrecommendations! Published in 2019 at "Gut and Liver"
DOI: 10.5009/gnl18488
Abstract: Background/Aims The natural history of spontaneous decrease in the size of pancreatic cystic lesions (PCLs) without high-risk stigmata is under investigation. This study aimed to investigate the timing of spontaneous decrease in the size of… read more here.
Keywords: risk stigmata; high risk; without high; size ... See more keywords